Summaries & Associations of Study Results
Levels from TR-519 Stoddard Solvent IIC
Target Organs and Levels of Evidence
NTP Technical Report Number 519
Produced from Chemtrack Database 02/07/06
| CHEMICAL/ CAS NUMBER | PEER REVIEW DATE | PRIMARY USES | ROUTE/EXPOSURE LEVELS | STUDY LABORATORY |
|---|---|---|---|---|
| STODDARD SOLVENT (TYPE IIC) 64742-88-7 |
05/22/03 | PETROLEUM SOLVENT; USES INCLUDE PAINT VEHICLES; THINNING AGENT FOR PAINTS, COATINGS, AND WAXES; PRINTING INKS; ADHESIVES; SOLVENT IN LIQUID PHOTOCOPIER TONERS; SOLVENT IN DRY CLEANING; DEGREASES FOR ENGINE PARTS IN MACHINE & AUTO REPAIR SHOPS. | Inhalation MR: 0, 188, 550, OR 1100 MG/M3; FR & M: 0, 550, 1100, OR 2200 MG/M3 | Battelle Northwest Laboratory |
| LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM): | ||||
| MR: SOME EVIDENCE | ADRENAL MEDULLA: BENIGN PHEOCHROMOCYTOMA 5/50 9/50 13/50 17/50 BENIGN OR MALIGNANT PHEOCHROMOCYTOMA 6/50 9/50 13/50 19/50 | |||
| MAY HAVE BEEN RELATED: | KIDNEY TUBULAR CELL: (STANDARD AND EXTENDED EVALUATION COMBINED) ADENOMA 3/50 2/50 3/50 7/50 | |||
| NON-NEOPLASTIC LESIONS: | KIDNEY: RENAL TUBULE HYPERPLASIA; TRANSITIONAL EPITHELIAL HYPERPLASIA; PAPILLA MINERALIZATION; INCREASED SEVERITY OF NEPHROPATHY | |||
| FR: NO EVIDENCE | ||||
| MM: NO EVIDENCE | ||||
| FM: EQUIVOCAL EVIDENCE | ||||
| MAY HAVE BEEN RELATED: | LIVER: ADENOMA 9/50 12/50 15/50 18/50 | |||
Web page last updated on February 10, 2006
